Raltegravir
Raltegravir (pronunciation: ral-TEG-ra-vir) is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for both prevention in those who have been exposed to HIV and treatment of those already infected.
Etymology
The name "Raltegravir" is derived from its chemical structure. The "Ral" part of the name is an abbreviation of "raloxifene", a similar compound. The "tegravir" part of the name is a common suffix for integrase inhibitors, which is the class of drugs that Raltegravir belongs to.
Usage
Raltegravir is used in combination with other antiretroviral therapies (ART) to treat HIV-1 infection in adults, adolescents, and children weighing at least 2 kg. It works by inhibiting the integrase enzyme, which is necessary for the virus to replicate in the body.
Side Effects
Common side effects include nausea, headache, and trouble sleeping. Severe side effects may include rhabdomyolysis, liver problems, and allergic reactions.
Related Terms
- Integrase inhibitor
- Antiretroviral medication
- HIV/AIDS
- Rhabdomyolysis
- Liver problems
- Allergic reactions
See Also
External links
- Medical encyclopedia article on Raltegravir
- Wikipedia's article - Raltegravir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski